v3.26.1
Stockholders’ Equity (Deficit) (Details Narrative) - USD ($)
 12 Months Ended
Jan. 01, 2026
Aug. 01, 2025
Jul. 11, 2025
Jul. 08, 2025
Jun. 24, 2025
May 13, 2025
May 01, 2025
Apr. 11, 2025
Mar. 20, 2025
Mar. 07, 2025
Feb. 03, 2025
Dec. 31, 2025
Dec. 31, 2024
Nov. 05, 2024
Nov. 04, 2024
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Gross proceeds warrants         $ 10,000,000.0             $ 2,672,500    
Fair value         265,957                    
Additional issuance costs         $ 74,000                    
Stock based compensation expense                       222,831 705,567    
Unrecognized stock-based compensation expense                       $ 208,316 $ 321,893    
Weighted average period     3 years                 1 year 10 months 24 days 1 year 3 months 18 days    
Exercise price       $ 1.00                      
Gross proceeds                       $ 1,999,791    
Warrant term                       5 years      
Other costs                       $ 290,317 212,102    
Proceeds from issuance of common stock                       1,354,404    
Inducement Warrants [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Exercise price       $ 0.67                      
Other fees       $ 41,852                      
Number of shares of common stock issued pursuant to the holder's exercise of existing warrants percentage rate       200.00%                      
March 2025 PreFunded Warrants [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Exercise price                       $ 0.0001      
December 2023 Offering [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Gross proceeds warrants     $ 201,296                        
Private Placement [Member] | March 2025 PreFunded Warrants [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Exercise price                   $ 0.0001          
Warrant purchase                   2,105,265          
Transaction costs                       $ 290,317      
Placement fees                       199,863      
Other fees                       64,312      
Other costs                       $ 26,142      
Private Placement [Member] | March 2025 Common Warrants [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Warrant purchase                   2,105,265          
Private Placement [Member] | March 2025 Common Warrants And Prefunded Warrants [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Exercise price                   $ 0.9499   $ 1.00   $ 1.00 $ 2.06
Warrant purchase                           957,200  
Gross proceeds                   $ 2,000,000.0          
Transaction costs                   $ 53,890          
Research and Development Expenses [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Stock based compensation expense                       $ 10,345 61,789    
General and Administrative Expenses [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Stock based compensation expense                       212,486 643,778    
Common Stock [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Warrant modification costs       $ 1,762,756                      
Warrant [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Purchase of warrants     377,964   426,829                    
Exercise price     $ 0.59                        
Other costs                       175,222 3,408,613    
Proceeds from issuance of common stock                       $ 2,051,852 $ 2,514,088    
Series A2 Common Stock [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Warrant purchase       957,200                      
Series A3 Common Stock [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Warrant purchase       2,105,265                      
Series A4 Common Stock [Member] | Inducement Warrants [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Exercise price       $ 0.67                      
Warrant purchase       6,124,930                      
Transaction costs       $ 175,222                      
Warrant term       5 years                      
Proceeds from issuance of common stock       $ 2,051,852                      
Cash fee paid       $ 133,370                      
2022 Omnibus Equity Incentive Plan [Member] | Subsequent Event [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Number of shares increased 705,958                            
2022 Omnibus Equity Incentive Plan [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Common stock, shares authorized                       382,122      
Available for future issuance                       377,965      
Marketing Agreements [Member] | Common Stock [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Stock issued period of shares, common stock   160,000       100,000 100,000 100,000 100,000   60,000        
Prepaid expense   $ 29,600       $ 51,800 $ 51,800 $ 77,000 $ 70,100   $ 81,600        
Equity Purchase Agreement [Member] | ELOC Shares [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Gross proceeds warrants         $ 10,000,000.0